Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
410.95
-3.31 (-0.80%)
At close: Sep 18, 2026, 4:00 PM EDT
410.85
-0.10 (-0.02%)
After-hours: Sep 18, 2026, 7:30 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $451.38. The average 1-year stock price forecast is 9.84% higher than the current stock price, while the lowest is $393 (-4.37%) and the highest is $492 (+19.72%).
Price Target: $451.38 (+9.84%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 12 | 12 | 12 | 12 | 12 |
| Buy | 3 | 3 | 2 | 3 | 3 | 3 |
| Hold | 8 | 7 | 8 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $460 | Buy | Maintains | $460 | +11.94% | Sep 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $473 | Buy | Maintains | $473 | +15.10% | Sep 15, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $460 → $480 | Buy | Maintains | $460 → $480 | +16.80% | Sep 11, 2026 |
| Barclays | Barclays | Buy Maintains $457 | Buy | Maintains | $457 | +11.21% | Sep 11, 2026 |
| Bernstein | Bernstein | Buy Maintains $488 | Buy | Maintains | $488 | +18.75% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
196.24B
from 199.13B
Decreased by -1.45%
Revenue Next Year
200.39B
from 196.24B
Increased by 2.12%
EPS This Year
27.17
from 30.29
Decreased by -10.31%
EPS Next Year
29.54
from 27.17
Increased by 8.74%
EPS and Forward PE are based on non-GAAP adjusted numbers.